[ATX] YoY Quarter Result on 31-Mar-2017 [#Q4]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q4]
Profit Trend
QoQ- -3.22%
YoY- -27.99%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 34 -0 -77 616 1,447 15 0 -
PBT -1,368 -1,152 -1,802 -3,594 -2,808 -2,619 -2,248 -7.93%
Tax -34 0 0 0 0 -81 0 -
NP -1,334 -1,152 -1,802 -3,594 -2,808 -2,619 -2,248 -8.32%
Tax Rate - - - - - - - -
Total Cost 1,368 1,152 1,725 4,210 4,255 2,634 2,248 -7.93%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -3,898.12 273,022.75 2,337.94 -583.60 -194.09 -17,278.70 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.02 -0.03 -0.08 -0.16 -0.15 -0.13 -0.17 -29.97%
EPS Diluted -0.02 -0.03 -0.08 -0.16 -0.15 -0.13 -0.17 -29.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.